Rectal and seminal HIV-1 RNA decay towards virological suppression in infected MSM initiating dolutegravir/abacavir/lamivudine

Fernandez-Gonzalez Marta; Garcia Jose A.; Padilla Sergio; Garcia-Abellan Javier; Agullo Vanesa; Gutierrez Felix; Masia Mar

首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Rectal and seminal HIV-1 RNA decay towards virological suppression in infected MSM initiating dolutegravir/abacavir/lamivudine

【24h】

Rectal and seminal HIV-1 RNA decay towards virological suppression in infected MSM initiating dolutegravir/abacavir/lamivudine

机译：直肠和精液HIV-1 RNA衰减对感染MSM的病毒学抑制起始DoluteGravir / Abacavir / Lamivudine

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: The time at which the protective effect of starting ART is achieved in male rectal and genital reservoirs is not clearly established.

机译：背景：在雄性直肠和生殖器储层中实现起始艺术的保护作用的时间没有明确建立。

著录项

来源
《The Journal of Antimicrobial Chemotherapy》 |2020年第3期|共7页
作者
Fernandez-Gonzalez Marta; Garcia Jose A.; Padilla Sergio; Garcia-Abellan Javier; Agullo Vanesa; Gutierrez Felix; Masia Mar;
展开▼
作者单位

Hosp Gen Elche Infect Dis Unit Alicante Spain;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Rectal and seminal HIV-1 RNA decay towards virological suppression in infected MSM initiating dolutegravir/abacavir/lamivudine [J] . Fernandez-Gonzalez Marta, Garcia Jose A., Padilla Sergio, The Journal of Antimicrobial Chemotherapy . 2020,第3期

机译：直肠和精液HIV-1 RNA衰减对感染MSM的病毒学抑制起始DoluteGravir / Abacavir / Lamivudine
2. Switching from abacavir/lamivudine plus nevirapine to abacavir/lamivudine/dolutegravir in virologically controlled HIV-infected adults (SWAD study) [J] . Allavena C., Volteau C., Andre-Garnier E., Medecine et maladies infectieuses . 2019,第7期

机译：从Abacavir / Lamivudine Plus Nevirapine切换到病毒学控制的艾滋病毒感染的成人中的Abacavir / Lamivudine / Dolutegravir（瑞士研究）
3. Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice [J] . Alberto Borghetti, Francesca Lombardi, Roberta Gagliardini, BMC Infectious Diseases . 2019,第1期

机译：与病毒抑制的HIV-1阳性个体中拉米夫定加上PIS的疗效和耐受性与跛行型阳性患者进行病毒学抑制：临床实践中的回顾性研究
4. The alternate metabolism of abacavir and its role in immunemediated hypersensitivity reactions in HIV-infected individuals [C] . Jeremy Netto, Niamh Keane, Ian Mullaney, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2009

机译：Abacavir的交替代谢及其在艾滋病毒感染个体中免疫化过敏反应中的作用
5. Intracellular drug -drug interaction between nucleoside analogs leads to early virologic failure in HIV patients receiving triple nucleoside combinations of tenofovir, lamivudine and abacavir or didanosine. [D] . Bi, Lucun. 2007

机译：核苷类似物之间的细胞内药物相互作用会导致接受替诺福韦，拉米夫定和阿巴卡韦或二羟肌苷的三核苷组合的HIV患者出现早期病毒学衰竭。
6. Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice [O] . Alberto Borghetti, Francesca Lombardi, Roberta Gagliardini, 2019

机译：拉米夫定加多洛格韦与拉米夫定加增强的PI在具有病毒学抑制作用的HIV-1阳性患者中的疗效和耐受性：来自临床实践的回顾性研究
7. Dolutegravir–lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study [O] . Pedro Cahn, María José Rolón, María Inés Figueroa, 2017

机译：Dolutegravir-lamivudine作为HIV-1感染，aRV初治患者的初始治疗，paDDLE的48周结果（polute antiretroviral Design with Dolutegravir LamivudinE）研究

Rectal and seminal HIV-1 RNA decay towards virological suppression in infected MSM initiating dolutegravir/abacavir/lamivudine

摘要

著录项

相似文献

相关主题

期刊订阅